Page last updated: 2024-11-05

troglitazone and Asymmetric Diabetic Proximal Motor Neuropathy

troglitazone has been researched along with Asymmetric Diabetic Proximal Motor Neuropathy in 2 studies

Troglitazone: A chroman and thiazolidinedione derivative that acts as a PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS (PPAR) agonist. It was formerly used in the treatment of TYPE 2 DIABETES MELLITUS, but has been withdrawn due to hepatotoxicity.

Research Excerpts

ExcerptRelevanceReference
"Troglitazone was less effective in controlling serum cholesterol and neuropathy."1.31Effects of peroxisome proliferator-activated receptor-alpha and -gamma agonist, JTT-501, on diabetic complications in Zucker diabetic fatty rats. ( Kakimoto, K; Shibata, T; Takeuchi, S; Wakitani, K; Yokota, S; Yonemori, F, 2000)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Qiang, X1
Satoh, J1
Sagara, M1
Fukuzawa, M1
Masuda, T1
Sakata, Y1
Muto, G1
Muto, Y1
Takahashi, K1
Toyota, T1
Shibata, T1
Takeuchi, S1
Yokota, S1
Kakimoto, K1
Yonemori, F1
Wakitani, K1

Other Studies

2 other studies available for troglitazone and Asymmetric Diabetic Proximal Motor Neuropathy

ArticleYear
Inhibitory effect of troglitazone on diabetic neuropathy in streptozotocin-induced diabetic rats.
    Diabetologia, 1998, Volume: 41, Issue:11

    Topics: Animals; Antioxidants; Blood Glucose; Body Weight; Chromans; Diabetes Mellitus, Experimental; Diabet

1998
Effects of peroxisome proliferator-activated receptor-alpha and -gamma agonist, JTT-501, on diabetic complications in Zucker diabetic fatty rats.
    British journal of pharmacology, 2000, Volume: 130, Issue:3

    Topics: Absorptiometry, Photon; Animals; Body Weight; Bone Density; Bone Diseases, Metabolic; Cataract; Chro

2000